Scientific Obfuscation II

The Letter to the Editor on the article :”Monoclonal antibodies for Emerging Infectious Disease – Borrowing from History” H.D. Marston, M.D., MPH, Catherine I. Paules, M.D., and Anthony S. Fauci,M.D., NEJM March 7,2018 remains unanswered as does my letter to the NIH..

However this week (April 19, 2018 edition) the NEJM republished the March 7, 2018 article with the addition of an audio interview with Dr. Anthony Fauci. How unusual to republish the article with further audio comment?

In 1996 I said monoclonals were potentially effective against viruses (US Patent). My work 22 years ago was significant. It appears that 22 years later the NIH agrees!!! Listen to the audio. There is no mention of my work. The audio discusses how important the concept appears to be! Of course the discussion includes the technical and cost issues of producing monoclonals. This is laying the basis for increased costs which is just business! (Notice that the price of some monoclonals was recently significantly reduced after many complaints). Its science vs money. With all the really bright researchers in the world – there is little doubt that someone or some group will improve the technology of making monoclonals and making them cost effective.

Monoclonals are effective and have, in general, fewer side effects than most other pharmaceuticals.

Linkedin Article:

US Patent 5,759,545

There are two ways to be fooled. One is to believe what is not true; the other is to refuse to believe what is true” – Soren Kirkergard

Dr. T. Ronald Theodore

Integrated Biologics, LLC